文献速递甲状腺疾病

TG-IGF1R:儿童甲状腺癌中的一种新型受体酪氨酸激酶融合癌基因

TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer.
PubMed 文献 · Thyroid · 2024-08-27

研究对一例缺乏其他常见驱动改变的甲状腺乳头状癌(PTC)进行RNA测序,在一名17岁女性血管侵袭性滤泡变异型PTC患者中报告了新型RTK融合TG-IGF1R。融合蛋白保留TG的胆碱酯酶样结构域及IGF1R的跨膜和激酶结构域,肿瘤样本显示IGF1R mRNA表达和酪氨酸激酶磷酸化增加、MAPK转录输出基因增强、NIS水平降低。作者认为该融合未纳入现有甲状腺特异性测序panel,将IGF1R融合筛查纳入下一代panel可能对患者有益。

要点

  • 在一名17岁女性血管侵袭性滤泡变异型PTC中报告新型RTK融合TG-IGF1R。
  • 融合蛋白保留TG胆碱酯酶样结构域及IGF1R跨膜和激酶结构域。
  • 肿瘤样本显示IGF1R mRNA表达和酪氨酸激酶磷酸化增加、MAPK转录输出基因增强、NIS水平降低。

核心结论

  • 研究揭示甲状腺癌中一种新型可靶向激酶融合癌基因TG-IGF1R,该融合未纳入不同甲状腺特异性测序panel。

研究设计与样本

  • 对一例缺乏其他常见驱动改变的甲状腺乳头状癌(PTC)进行RNA测序。

主要发现

  • 在一名17岁女性血管侵袭性滤泡变异型PTC患者中报告TG-IGF1R融合。
  • 融合蛋白保留TG的胆碱酯酶样结构域(具有二聚化特性)及IGF1R的跨膜和激酶结构域。
  • 肿瘤样本显示IGF1R mRNA表达增加和酪氨酸激酶磷酸化增加。
  • 肿瘤样本显示MAPK转录输出基因增强、NIS水平降低。

临床怎么用

  • 作者认为,将IGF1R融合筛查纳入下一代甲状腺特异性靶向下一代测序panel可能对甲状腺癌患者有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Receptor tyrosine kinase (RTK) fusions of RET, NTRK1/3, and ALK are enriched among pediatric thyroid cancer patients with metastatic and persistent disease, and their oncoproteins represent attractive drug targets. Methods: We performed RNA-sequencing in a papillary thyroid cancer (PTC) lacking other frequent driver alterations. Results: We report a novel RTK fusion, TG-insulin-like growth factor 1 receptor gene (IGF1R), in a 17-year-old female patient with angioinvasive follicular variant PTC. The in-frame fusion protein preserves the cholinesterase-like domain of TG with dimerization properties and the transmembrane and kinase domain of IGF1R. The tumor sample shows increased IGF1R mRNA expression and tyrosine kinase phosphorylation, augmentation of Mitogen activated protein kinase (MAPK) transcriptional output genes, and decreased NIS levels. Conclusions: We reveal a novel targetable kinase fusion oncogene in thyroid cancer which is not incorporated in different thyroid-specific sequencing panels. The integration of IGF1R fusion screening in the next versions of thyroid-specific targeted next-generation sequencing panels may be beneficial to thyroid cancer patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ricarte-Filho JC, Reichenberger ER, Hinkle K, et al. TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer. Thyroid. 2024. PMID: 39104254. doi:10.1089/thy.2024.0224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。